98 related articles for article (PubMed ID: 21605678)
1. Purification and characterization of tagless recombinant human elongation factor 2 kinase (eEF-2K) expressed in Escherichia coli.
Abramczyk O; Tavares CD; Devkota AK; Ryazanov AG; Turk BE; Riggs AF; Ozpolat B; Dalby KN
Protein Expr Purif; 2011 Oct; 79(2):237-44. PubMed ID: 21605678
[TBL] [Abstract][Full Text] [Related]
2. Revealing eEF-2 kinase: recent structural insights into function.
Piserchio A; Dalby KN; Ghose R
Trends Biochem Sci; 2024 Feb; 49(2):169-182. PubMed ID: 38103971
[TBL] [Abstract][Full Text] [Related]
3. Combined treatment of mitoxantrone sensitizes breast cancer cells to rapalogs through blocking eEF-2K-mediated activation of Akt and autophagy.
Guan Y; Jiang S; Ye W; Ren X; Wang X; Zhang Y; Yin M; Wang K; Tao Y; Yang J; Cao D; Cheng Y
Cell Death Dis; 2020 Nov; 11(11):948. PubMed ID: 33144562
[TBL] [Abstract][Full Text] [Related]
4. Molecular control of the amount, subcellular location, and activity state of translation elongation factor 2 in neurons experiencing stress.
Argüelles S; Camandola S; Hutchison ER; Cutler RG; Ayala A; Mattson MP
Free Radic Biol Med; 2013 Aug; 61():61-71. PubMed ID: 23542375
[TBL] [Abstract][Full Text] [Related]
5. Recombinant protein production for structural and kinetic studies: A case study using M. tuberculosis α-methylacyl-CoA racemase (MCR).
Mojanaga OO; Acharya KR; Lloyd MD
Methods Enzymol; 2023; 690():1-37. PubMed ID: 37858526
[TBL] [Abstract][Full Text] [Related]
6. A low-cost and open-source protocol to produce key enzymes for molecular detection assays.
Mendoza-Rojas G; Sarabia-Vega V; Sanchez-Castro A; Tello L; Cabrera-Sosa L; Nakamoto JA; Peñaranda K; Adaui V; Alcántara R; Milón P
STAR Protoc; 2021 Dec; 2(4):100899. PubMed ID: 34766029
[TBL] [Abstract][Full Text] [Related]
7. Cloning, expression, and functional characterization of in-house prepared human leukemia inhibitory factor.
Rassouli H; Nemati S; Rezaeiani S; Sayadmanesh A; Gharaati MR; Salekdeh GH; Baharvand H; Gourabi H
Cell J; 2013; 15(2):190-7. PubMed ID: 23862122
[TBL] [Abstract][Full Text] [Related]
8. Arrestin-3-Dependent Activation of c-Jun N-Terminal Kinases (JNKs).
Zhan X; Kaoud TS; Dalby KN; Gurevich EV; Gurevich VV
Curr Protoc; 2023 Sep; 3(9):e839. PubMed ID: 37668419
[TBL] [Abstract][Full Text] [Related]
9. ADP enhances the allosteric activation of eukaryotic elongation factor 2 kinase by calmodulin.
Piserchio A; Long KJ; Browning LS; Bohanon AL; Isiorho EA; Dalby KN; Ghose R
Proc Natl Acad Sci U S A; 2023 Apr; 120(17):e2300902120. PubMed ID: 37068230
[TBL] [Abstract][Full Text] [Related]
10. eEF2K Inhibitor Design: The Progression of Exemplary Structure-Based Drug Design.
Klupt KA; Jia Z
Molecules; 2023 Jan; 28(3):. PubMed ID: 36770760
[TBL] [Abstract][Full Text] [Related]
11. Insights Into the Pathologic Roles and Regulation of Eukaryotic Elongation Factor-2 Kinase.
Ballard DJ; Peng HY; Das JK; Kumar A; Wang L; Ren Y; Xiong X; Ren X; Yang JM; Song J
Front Mol Biosci; 2021; 8():727863. PubMed ID: 34532346
[TBL] [Abstract][Full Text] [Related]
12. Target-Driven Design of a Coumarinyl Chalcone Scaffold Based Novel EF2 Kinase Inhibitor Suppresses Breast Cancer Growth
Comert Onder F; Kahraman N; Bellur Atici E; Cagir A; Kandemir H; Tatar G; Taskin Tok T; Kara G; Karliga B; Durdagi S; Ay M; Ozpolat B
ACS Pharmacol Transl Sci; 2021 Apr; 4(2):926-940. PubMed ID: 33860211
[TBL] [Abstract][Full Text] [Related]
13. Solution Structure of the Carboxy-Terminal Tandem Repeat Domain of Eukaryotic Elongation Factor 2 Kinase and Its Role in Substrate Recognition.
Piserchio A; Will N; Giles DH; Hajredini F; Dalby KN; Ghose R
J Mol Biol; 2019 Jul; 431(15):2700-2717. PubMed ID: 31108082
[TBL] [Abstract][Full Text] [Related]
14. Structural Dynamics of the Activation of Elongation Factor 2 Kinase by Ca
Will N; Lee K; Hajredini F; Giles DH; Abzalimov RR; Clarkson M; Dalby KN; Ghose R
J Mol Biol; 2018 Aug; 430(17):2802-2821. PubMed ID: 29800565
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase.
Bayraktar R; Pichler M; Kanlikilicer P; Ivan C; Bayraktar E; Kahraman N; Aslan B; Oguztuzun S; Ulasli M; Arslan A; Calin G; Lopez-Berestein G; Ozpolat B
Oncotarget; 2017 Feb; 8(7):11641-11658. PubMed ID: 28036267
[TBL] [Abstract][Full Text] [Related]
16. Signal Integration at Elongation Factor 2 Kinase: THE ROLES OF CALCIUM, CALMODULIN, AND SER-500 PHOSPHORYLATION.
Tavares CDJ; Giles DH; Stancu G; Chitjian CA; Ferguson SB; Wellmann RM; Kaoud TS; Ghose R; Dalby KN
J Biol Chem; 2017 Feb; 292(5):2032-2045. PubMed ID: 27956550
[TBL] [Abstract][Full Text] [Related]
17. A high-throughput screening assay for eukaryotic elongation factor 2 kinase inhibitors.
Xiao T; Liu R; Proud CG; Wang MW
Acta Pharm Sin B; 2016 Nov; 6(6):557-563. PubMed ID: 27818922
[TBL] [Abstract][Full Text] [Related]
18. Structure of the C-Terminal Helical Repeat Domain of Eukaryotic Elongation Factor 2 Kinase.
Will N; Piserchio A; Snyder I; Ferguson SB; Giles DH; Dalby KN; Ghose R
Biochemistry; 2016 Sep; 55(38):5377-86. PubMed ID: 27571275
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
